Hematoma, Intracerebral Hemorrhage, Stroke
Conditions
Brief summary
The intracerebral hemorrhage study is a multicenter , combination of prospective and retrospective observational cohort study led by Dr. Muhammad Junaid Akram, PhD scholar at Chongqing Medical University. Prof Dr. Qi Li will be the senior consultant for the study. The study will be focusing on natural history, epidemiological , radiological, rehabilitative and clinical aspects as well as the effect of various treatments on the hemorrhagic patients. The study related data of the patients diagnosed with intracerebral hemorrhage will be collected in prospective and retrospective ways. The prognostic data for the patients will be assembled and collected via using different outcome measures at different points of time.
Detailed description
The study will be used to address the several key issues related to intracerebral hemorrhage. The demographics, scores based upon disease severity , mRS, GCS, NIHSS scores will be recorded at baseline and in the prospective and retrospective ways. The data obtained from the registered patients will be used for future use , critical review by expert neurologists, neurorehabilitative experts for further use and review.
Interventions
None listed
Sponsors
Shifa International Hospital
Chongqing Medical University
Shifa Clinical Research Center
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age \> 18 years Patients willing to participate via signing a consent form' Patients diagnosed with CT-Confirmed spontaneous intracerebral hemorrhage (ICH) Patients willing to participate in the follow up assessment
Exclusion criteria
* Not willing to participate Secondary ICH to hemorrhagic infarction or tumor bleeding etc. Traumatic ICH
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| hematoma volume growth at 24 hours | 24 hours | To assess early hematoma volume growth at 24 hours |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Early neurological deterioration assessed by NIHSS score at 24 hours | 24 hours | To assess early neurological deterioration by using NIHSS score at 24 hours |
| Early neurological deterioration assessed by NIHSS score at 48 hours | 48 hours | To assess early neurological deterioration by using NIHSS score at 48 hours |
| Early neurological deterioration assessed by NIHSS score at 72 hours | 72 hours | To assess early neurological deterioration by using NIHSS score at 72 hours |
| Perihematomal edema volume measurement at 24 hours | 24 hours | To measure the perihematomal edema volume growth at 24 hours |
| Functional outcome at 3 months assessed by modified Rankin Scale | 3 months | Assess functional outcome at 3 months by using mRS |
| Perihematomal edema volume measurement at 72 hours | 72 hours | To measure the perihematomal edema volume growth at 72 hours |
| Intraventricular hemorrhage growth | 24 hours | To assess the presence of IVH at 24 hours |
| Major thrombotic events | 2 weeks | To assess the thrombotic events 2 weeks after admission |
| Perihematomal edema volume measurement at 48 hours | 48 hours | To measure the perihematomal edema volume growth at 48 hours |
Countries
Pakistan
Contacts
Primary ContactMuhammad Junaid Akram, DPT, MS-NMPT
Backup ContactMuhammad Junaid Akram
Outcome results
None listed